Co-Authors
This is a "connection" page, showing publications co-authored by Robert Bals and Claus Vogelmeier.
Connection Strength
1.176
-
Left ventricular volume and wall stress are linked to lung function impairment in COPD. Int J Cardiol. 2018 06 15; 261:172-178.
Score: 0.193
-
Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV1 in individuals with PiZZ alpha-1-antitrypsin deficiency. Respir Med. 2017 08; 129:8-15.
Score: 0.179
-
Inhibition of NF-kappaB mediated inflammation by siRNA expressed by recombinant adeno-associated virus. J Virol Methods. 2004 Sep 01; 120(1):119-22.
Score: 0.074
-
Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET. ERJ Open Res. 2021 Jul; 7(3).
Score: 0.060
-
Efficacy and safety of inhaled a1-antitrypsin in patients with severe a1-antitrypsin deficiency and frequent exacerbations of COPD. Eur Respir J. 2019 11; 54(5).
Score: 0.053
-
Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort. Patient Prefer Adherence. 2019; 13:1711-1721.
Score: 0.053
-
Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort. Int J Chron Obstruct Pulmon Dis. 2019; 14:2163-2172.
Score: 0.053
-
Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD. Respir Res. 2019 Mar 27; 20(1):61.
Score: 0.051
-
Genome-wide MicroRNA Expression Profiles in COPD: Early Predictors for Cancer Development. Genomics Proteomics Bioinformatics. 2018 06; 16(3):162-171.
Score: 0.048
-
Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach. Respir Res. 2018 06 04; 19(1):110.
Score: 0.048
-
Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling. Respir Med. 2018 04; 137:14-22.
Score: 0.047
-
The revised GOLD 2017 COPD categorization in relation to comorbidities. Respir Med. 2018 01; 134:79-85.
Score: 0.047
-
Cardiovascular risk in patients with alpha-1-antitrypsin deficiency. Respir Res. 2017 09 15; 18(1):171.
Score: 0.046
-
Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZ. Respir Med. 2017 Sep; 130:1-8.
Score: 0.045
-
Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort. PLoS One. 2017; 12(5):e0177501.
Score: 0.045
-
Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry. Int J Chron Obstruct Pulmon Dis. 2017; 12:1427-1437.
Score: 0.045
-
Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients. Respir Res. 2017 04 17; 18(1):60.
Score: 0.045
-
Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort. Respir Res. 2017 01 13; 18(1):14.
Score: 0.044